Management of sickle cell anemia is usually aimed at avoiding pain episodes, relieving symptoms and preventing complications. Treatments might include medicines and blood transfusions. For some children and teenagers, a stem cell transplant might cure the disease. Gene therapies also are being developed that may offer cures for people with sickle cell disease.
Medicines
- Hydroxyurea (Droxia, Hydrea). Daily hydroxyurea reduces the frequency of pain crises and might reduce the need for blood transfusions and hospital stays. But it can increase the risk of infections. Don't take the drug if you're pregnant.
- L-glutamine oral powder (Endari). It helps in reducing the frequency of pain crises.
- Crizanlizumab (Adakveo). This medicine, given by injection, can help reduce the frequency of pain crises in adults and in children older than 16 years. Side effects can include nausea, joint pain, back pain and fever.
- Voxelotor (Oxbryta). This medicine is used to treat sickle cell disease in adults and in children older than 12 years. Taken by mouth, this medicine can lower the risk of anemia and improve blood flow throughout the body. Side effects can include headache, nausea, diarrhea, fatigue, rash and fever.
- Pain-relieving medicines. Your healthcare professional might prescribe narcotics to help relieve pain during sickle cell pain crises.
Preventing infections
Children with sickle cell anemia might receive penicillin from about 2 months old to 5 years old, or longer. This medicine can help prevent infections, such as pneumonia, which can be life-threatening to children with sickle cell anemia.
Adults who have sickle cell anemia might need to take penicillin throughout their lives if they've had pneumonia or surgery to remove the spleen.
Childhood vaccinations are important for preventing disease in all children. Vaccinations are even more important for children with sickle cell anemia because their infections can be severe.
Your child's healthcare team should make sure that your child gets all the recommended childhood vaccinations. These include vaccines against pneumonia, meningitis, hepatitis B and a yearly flu shot. Vaccines also are important for adults with sickle cell anemia.
During global health threats, such as the COVID-19 pandemic, people with sickle cell anemia should take extra precautions. These include staying at home as much as possible and for those who are eligible, getting vaccinated.
Surgical and other procedures
-
Blood transfusions. Red blood cell transfusions are used to treat and prevent complications, such as stroke, in people with sickle cell disease.
In this procedure red blood cells are removed from a supply of donated blood, then given through a vein to a person with sickle cell anemia. This increases the number of red blood cells that are not affected by sickle cell anemia. This helps reduce symptoms and complications.
Risks include an immune response to the donor blood, which can make it hard to find future donors. Infection and excess iron buildup in the body are other risks. Because excess iron can damage your heart, liver and other organs, you might need treatment to reduce iron levels if you undergo regular transfusions.
-
Stem cell transplant. This also is known as a bone marrow transplant. The procedure involves replacing bone marrow affected by sickle cell anemia with bone marrow from a donor. The procedure usually uses a matched donor, such as a sibling, who doesn't have sickle cell anemia.
A stem cell transplant can cure sickle cell anemia. Stem cell transplant is recommended only for people, usually children, who have significant symptoms and complications of sickle cell anemia. The risks associated with the procedure are high and include death.
-
Stem cell gene addition therapy. In this treatment option, the person's own stem cells are removed, and a gene to produce typical hemoglobin is injected. The stem cells are then given back to the person in a process known as autologous transplant. This option may be a cure for people with sickle cell disease who do not have a well-matched donor.
-
Gene editing therapy. This Food and Drug Administration (FDA)-approved treatment works by making changes to the DNA in a person's stem cells. Stem cells are removed from the body, and the sickle gene is changed, also called edited, to help restore the cells' ability to make healthy red blood cells. The treated stem cells are then returned to the body through the blood. This is called an infusion.
People who are successfully treated with gene editing therapy no longer have symptoms of sickle cell disease. This treatment is FDA-approved for people 12 years old and older. Long-term effects of this new treatment are not yet known and will continue to be studied.
Clinical trials are ongoing to address stem cell transplantation in adults and gene therapies.